EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Seeding amplification assay with Universal Control Fluid: Standardized detection of α-synucleinopathies

Remarh Bsoul iD, Anja H Simonsen, Kristian S Frederiksen, Kirsten Svenstrup, Sara Bech, Lisette Salvesen, Anne-Mette Hejl, Marcello Rossi, Piero Parchi, Eva L Lund iD, Aušrinė Areškevičiūtė iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0326568 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Remarh Bsoul und 10 weiteren Autor:innen. Beteiligte Einrichtung: Danish Reference Center for Prion Diseases, Department of Pathology, Copenhagen University Hospital, Copenhagen, Denmark. Hauptthemen laut MEDLINE: alpha-Synuclein, Synucleinopathies. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Seeding amplification assays, specifically the Real-Time Quaking-Induced Conversion method (RT-QuIC), have shown great diagnostic potential for α-synucleinopathies. Numerous research groups have demonstrated the method’s high sensitivity and specificity using cerebrospinal fluid (CSF) samples and various RT-QuIC workflows. However, establishing a uniform and stably performing RT-QuIC protocol remains challenging. To address this, we established an RT-QuIC protocol with a Universal Control Fluid (UCF), which is simple to adopt, performs stably, and allows uniform preparation of both sample and control reactions. Firstly, we adapted and established a published 48-hour RT-QuIC protocol, including the in-house production of recombinant α-synuclein (rec α-syn), and evaluated its sensitivity and specificity through a blinded screening of an 81 CSF sample cohort consisting of Parkinson’s disease (PD), dementia with Lewy bodies (DLB), Alzheimer’s disease, motor neuron disease, multiple system atrophy, unidentified neurodegenerative diseases, and healthy controls. Additionally, we tested all CSF samples in three volumes to determine which volume provides the best diagnostic accuracy. The established RT-QuIC performs nearly equally well with 7 µL and 15 µL added CSF, resulting in 94% and 94.5% diagnostic accuracy, respectively. Secondly, we developed a UCF solution and tested its performance with the established RT-QuIC protocol. Results indicate that UCF, used in defined volume and concentration, standardizes the preparation of both sample and control reactions without compromising the assay’s diagnostic accuracy and provides a stabilizing environment for the reactions, ensuring higher reproducibility. The established RT-QuIC protocol for pathologic α-synuclein detection in PD and DLB CSF samples is highly sensitive (92–96%) and specific (93–96%). Therefore, it is important that its adoption in clinical laboratories is uncomplicated and uniform. RT-QuIC with UCF simplifies, standardizes, and stabilizes the assay’s performance and, thus, could be recommended as a standard protocol for accurate detection of α-synucleinopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinSynucleinopathiesHumansParkinson DiseaseSensitivity and SpecificityLewy Body DiseaseMaleAgedFemaleMultiple System Atrophy

Substanzen

alpha-Synuclein

Autor:innen und Institutionen

  • Danish Reference Center for Prion Diseases, Department of Pathology, Copenhagen University Hospital, Copenhagen, Denmark.
  • Danish Dementia Research Centre, Copenhagen University Hospital, Copenhagen, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Department of Neurology, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
  • Department of Neurology, Copenhagen University Hospital, Copenhagen, Denmark.
  • IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.

ORCID-Profile: Remarh Bsoul, Eva L Lund, Aušrinė Areškevičiūtė

Zitieren

APA

Bsoul, R., Simonsen, A. H., Frederiksen, K. S., Svenstrup, K., Bech, S., Salvesen, L., Hejl, A. M., Rossi, M., Parchi, P., Lund, E. L., & Areškevičiūtė, A. (2025). Seeding amplification assay with Universal Control Fluid: Standardized detection of α-synucleinopathies. PLOS One. https://doi.org/10.1371/journal.pone.0326568

Vancouver

Bsoul R, Simonsen AH, Frederiksen KS, Svenstrup K, Bech S, Salvesen L, et al. Seeding amplification assay with Universal Control Fluid: Standardized detection of α-synucleinopathies. PLOS One. 2025. doi:10.1371/journal.pone.0326568

BibTeX
@article{Bsoul2025,
  author = {Bsoul, Remarh and Simonsen, Anja H and Frederiksen, Kristian S and Svenstrup, Kirsten and Bech, Sara and Salvesen, Lisette and Hejl, Anne-Mette and Rossi, Marcello and Parchi, Piero and Lund, Eva L and Areškevičiūtė, Aušrinė},
  title = {Seeding amplification assay with Universal Control Fluid: Standardized detection of α-synucleinopathies},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0326568}
}
Kostenlos starten →